Total planned funding: $1,531,174,290
Clear active filters
Chemonics International
Private Contractor
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $311,630,153 |
Zambia | $226,686,011 |
Kenya | $182,444,439 |
Tanzania | $165,249,319 |
Mozambique | $145,683,092 |
Uganda | $145,534,235 |
Zimbabwe | $63,799,502 |
Democratic Republic of the Congo | $56,680,027 |
Haiti | $42,020,812 |
Rwanda | $33,747,176 |
Ethiopia | $27,727,598 |
Côte d'Ivoire | $22,670,140 |
Cameroon | $16,218,985 |
Eswatini | $14,721,183 |
West Africa Region | $11,139,691 |
Malawi | $9,980,921 |
Western Hemisphere Region | $9,561,082 |
Burundi | $9,286,845 |
South Africa | $8,242,059 |
Namibia | $7,319,438 |
Asia Regional Program | $5,949,606 |
Lesotho | $5,796,990 |
Vietnam | $3,717,152 |
Angola | $3,634,305 |
Ukraine | $1,100,000 |
enumerations.Philippines | $358,416 |
Botswana | $275,113 |
Organizational Types
Private Contractor | $1,531,174,290 |
Program Areas
Treatment | $1,260,850,968 |
Care | $116,009,082 |
Prevention | $88,765,358 |
Governance and Systems | $53,667,798 |
Testing | $10,226,921 |
Budget Codes
HTXD: Treatment: ARV Drugs | $820,280,187 |
HTXS: Treatment: Adult Treatment | $360,330,219 |
PDTX: Treatment: Pediatric Treatment | $80,240,562 |
HVTB: Care: TB/HIV | $50,850,013 |
OHSS: Health Systems Strengthening | $44,011,100 |
HBHC: Care: Adult Care and Support | $38,347,648 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $38,304,195 |
HVOP: Sexual Prevention: Other Sexual Prevention | $32,881,691 |
PDCS: Care: Pediatric Care and Support | $19,633,955 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $13,223,166 |
HVCT: Testing: HIV Testing and Counseling | $10,226,921 |
HKID: Care: Orphans and Vulnerable Children | $7,177,466 |
HLAB: Laboratory Infrastructure | $6,751,718 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $3,192,541 |
HVSI: Strategic Information | $2,904,980 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $1,151,765 |
HMIN: Biomedical Prevention: Injection Safety | $12,000 |
Top Partner Programs
Chemonics International:
$1,531,174,290
View countries